ADIMMUNE CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.5 TWD | -0.52% |
|
+0.18% | -14.03% |
| 05-15 | Adimmune Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-28 | Adimmune Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 371M | - | - | - | - | - | |
| 95.71B | ||||||
| 41.64B | ||||||
| 32.7B | ||||||
| 28.65B | ||||||
| 15.38B |
